Tandem t:slim X2 User Manual page 307

The table below describes the average time participants in both the Control-IQ technology group and the SAP group spent with
sensor glucose levels between 70–180 mg/dL by month at baseline and during the study period.
DCLP3: Percentage of Time in Range per Study Arm by Month (N=168)
Month
Baseline
Month 1
Month 2
Month 3
Month 4
Month 5
Month 6
DCLP5: Percentage of Time in Range per Study Arm by Month (N=101)
Month
Baseline
Month 1
Month 2
Month 3
Month 4
CHAPTER 32 • Overview of Control-IQ Technology Clinical Studies
Study Arm
(Control-IQ)
61%
73%
72%
71%
72%
71%
70%
Control-IQ
53%
68%
68%
67%
66%
Control Arm
(SAP)
59%
62%
60%
60%
58%
58%
58%
SAP
51%
56%
54%
56%
55%
305